Table 3 Comparative results of mean difference in coagulation profile among individuals using different lipid-lowering drugs
| Â | Adjusted mean differencea (95%CI) | Adjusted mean difference a (95% CI) | Adjusted mean difference a (95% CI) |
|---|---|---|---|
Fibrinogen, mg/dL | |||
 Fibrate/Niacin users | – | Reference | Reference |
 Other statin users | Reference | – | 18.6 (− 11.0 to 48.4) |
 Rosuvastatin users | 1.5 (−12.1 to 15.3) | – | 20.7 (− 6.2 to 47.6) |
 All statin users | – | 19.1(− 10.0 to 48.2) | – |
Factor VIII, IU/dL | |||
 Fibrate/Niacin users | – | Reference | Reference |
 Other statin users | Reference | – | − 15.5 (− 31.5 to 0.5) |
 Rosuvastatin users | −2.6 (− 10.1 to 4.7) | – | − 17.6 (− 33.8 to −1.3) |
 All statin users | – | − 15.8 (− 31.6 to 0.003) | – |
Factor IX, IU/dL | |||
 Fibrate/Niacin users | – | Reference | Reference |
 Other statin users | Reference | – | − 11.0 (− 22.7 to 0.7) |
 Rosuvastatin users | −2.3 (− 7.9 to 3.1) | – | − 14.9 (− 29.7 to − 0.08) |
 All statin users | – | −11.3 (− 23.2 to 0.4) | – |
Factor XI, IU/dL | |||
 Fibrate/Niacin users | – | Reference | Reference |
 Other statin users | Reference | – | −18.3 (− 27.4 to − 9.2) |
 Rosuvastatin users | 0.3 (−3.8 to 4.5) | – | −17.6 (− 27.4 to − 7.7) |
 All statin users | – | − 18.3 (− 27.3 to − 9.4) | – |